Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Main Inclusion Criteria:~* Clinical diagnosis of mild persistent asthma~* Pre-treatment with SABAs only~* FEV1 ≥80% predicted~* Good health with the exception of asthma~Main Exclusion Criteria:~* Concomitant severe diseases or diseases which are contraindications for the use of inhaled steroids~* COPD (chronic bronchitis or emphysema) and/or other relevant lung diseases causing alternating impairment in pulmonary function~* Pregnancy~* Intention to become pregnant during the course of the study~* Breast feeding~* Lack of safe contraception~* Current smokers ≥10 pack-years and ex-smokers with ≥10 pack-years

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).